From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Current drug resistance mechanisms and treatment options in gastrointestinal stromal tumors: Summary and update

Last Updated: Tuesday, November 26, 2024

This retrospective study analyzed survival outcomes of 174 metastatic GIST patients treated at a German referral center from 2008 to 2021. Median overall survival (OS) improved significantly compared to historical data, with OS of 7.1 years for imatinib, 2.9 years for sunitinib, and 1.9 years for regorafenib in respective treatment lines. Survival was influenced by metastatic site but not by prior perioperative imatinib or time to metastasis. The study offers valuable real-world survival data. 

Journal of Cancer Research and Clinical Oncology
Advertisement
News & Literature Highlights

Clinical Cancer Research

Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)

Oncology Letters

Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

Pharmaceutics

Tyrosine kinase inhibitors for gastrointestinal stromal tumor after imatinib resistance

Clinical Cancer Research

Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors

Gastric Cancer

Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors

Autophagy

Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity

Hematology/Oncology Clinics of North America

Gastrointestinal stromal tumor: Current approaches and future directions in the treatment of advanced disease

Oncologist

The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: Desensitization therapy and pharmacogenetic investigation

Cancers

Multifocal gastrointestinal stromal tumors (GISTs) of the small intestine in patients with neurofibromatosis type 1 (NF-1): Meta-analysis and systematic review of the literature

Healthcare

The many faces of intestinal tumors in adults, including the primary role of CT imaging in emergencies and the important role of cross-sectional imaging: A pictorial review

Advertisement
Advertisement